Trial intelligence / Profile preview

Durable Wall Liners for Malaria Control in Tanzania

NCT02533336Phase 3Terminated

Sponsor
National Institute for Medical Research
Start
Nov 2015
Primary completion
Aug 2016
Countries
1
01

Overview

Phase 3, randomised, open-label trial (2 arms), sponsored by National Institute for Medical Research. Primary endpoint: Incidence of malaria parasitemia at 1 year. Started Nov 2015; status: terminated.

Beyond the preview

Go deeper on NCT02533336.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02533336.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call